Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

5 Analysts Have This to Say About First Solar

Analysts have provided the following ratings for First Solar (NASDAQ:FSLR) within the last quarter:

5 Analysts Have This to Say About TG Therapeutics

5 Analysts Have This to Say About TG Therapeutics

Analysts have provided the following ratings for TG Therapeutics (NASDAQ:TGTX) within the last quarter:

4 Analysts Have This to Say About Fulcrum Therapeutics

4 Analysts Have This to Say About Fulcrum Therapeutics

Within the last quarter, Fulcrum Therapeutics (NASDAQ:FULC) has observed the following analyst ratings:

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Why Lensar Shares Are Trading Higher Today

The FDA granted 510(k) clearance to Lensar Inc's (NASDAQ:LNSR) next-generation ALLY Adaptive Cataract Treatment System (ALLY System). ALLY is the first FDA-cleared platform to enable cataract surgeons to complete the femtosecond-laser-assisted cataract surgery (FLACS) procedure seamlessly in a single, sterile environment. The company plans to deliver the first ALLY Systems to surgeons in Q3…

Why Hillstream BioPharma Shares Are Trading Higher Today?

Hillstream BioPharma Inc (NASDAQ:HILS) shares are trading higher after it authorized a share repurchase program to acquire up to $1 million in common stock. As of March 31, Hillstream had approximately $11.1 million in cash and 11.4 million shares of common stock. "We have demonstrated strong execution and, as a result, have seen significant advancement…

What's Next For NRx Pharma As FDA Denies Breakthrough Therapy Tag For COVID-19 Therapy

The FDA has denied NRx Pharmaceuticals Inc's (NASDAQ:NRXP) Breakthrough Therapy designation (BTD) request for Zyesami (aviptadil). The request for BTD was submitted based on a post-hoc subgroup analysis of patients who, in addition to aviptadil or placebo, were also treated with Gilead Sciences Inc's (NASDAQ: GILD) remdesivir and whose respiratory failure due to critical COVID-19 continued…

Analyst Ratings for CRISPR Therapeutics

CRISPR Therapeutics (NASDAQ:CRSP) has observed the following analyst ratings within the last quarter:

inkl

Read news from The Economist, FT, and more,
with one subscription

5 Biotech Stocks To Watch During The Week Of June 13

5 Biotech Stocks To Watch During The Week Of June 13

Biotech stocks continued to be under pressure in the past week amid broader market weakness, precipitated by economic worries. Company-specific developments also triggered downward moves. Here's a compilation of five stocks that should be on your radar in the week of June 13: 1. Novavax

R Madhavan's 'Rocketry: The Nambi Effect' trailer launched at Times Square

R Madhavan's 'Rocketry: The Nambi Effect' trailer launched at Times Square

Bollywood actor and filmmaker R Madhavan's biographical drama movie 'Rocketry: The Nambi Effect', which is based on the life of renowned scientist Nambi Narayanan, launched the trailer on the NASDAQ billboard at Times Square on Saturday.

What Tesla's 3-For-1 Split Means For The Battered Stock: 'A Smart Move By Board'

What Tesla's 3-For-1 Split Means For The Battered Stock: 'A Smart Move By Board'

Tesla, Inc. (NASDAQ: TSLA) finally filed a proxy statement with the SEC, wherein it revealed that it intends to implement a 3-for-1 split in the form of a stock dividend.

As Meta gives Sheryl Sandberg a send-off, a probe underway on resource misappropriation

As Meta gives Sheryl Sandberg a send-off, a probe underway on resource misappropriation

Sheryl Sandberg resigned from Meta Platforms Inc (NASDAQ: META) as COO last week after 14 years with the organization.

If You Invested $5,000 In Tesla, Apple Or Nvidia On Dec. 31 Here's How Much You've Lost And Why

If You Invested $5,000 In Tesla, Apple Or Nvidia On Dec. 31 Here's How Much You've Lost And Why

Apple, Inc (NASDAQ: AAPL), Tesla, Inc (NASDAQ: TSLA) and Nvidia Corporation (NASDAQ: NVDA) were slipping over 3%, 4% and 5% l

Google Agrees To Pay $118M To Settle Lawsuit Filed By Female Employees

Google Agrees To Pay $118M To Settle Lawsuit Filed By Female Employees

Alphabet Inc's (NASDAQ: GOOGL) Google has agreed to settle a gender discrimination lawsuit covering close to 15,500 female employees b

Elon Musk Predicts That Civilization Will Be Powered By This Energy Source In The Future

Elon Musk Predicts That Civilization Will Be Powered By This Energy Source In The Future

Tesla, Inc. (NASDAQ: TSLA) chief executive officer Elon Musk has made green energy a primary focus of his business endeavors. His EV venture is a testament to his commitment to protecting the environment.

Get all your
news in one place.

100’s of premium titles.
One news app.

Tesla Finally Confirms Stock Split Amid Plunge, Nio Unveils Plans For 2024, Fisker's Orders Overflow: Week's Top News From EV Industry

Electric vehicle stocks came under selling pressure once again in the week ending June 10 as macroeconomic fears engulfed the market. The weakness was concentrated in the final two sessions of the week, as Friday's inflation data rattled investors.

Is Elon Musk's Success A Result Of Reckless Betting, Extreme Luck And Folly? 'Black Swan' Author Has A Theory

“Black Swan” author Nassim Nicholas Taleb used Tesla Inc (NASDAQ: TSLA) CEO Elon Musk as an illustration of how people are fooled by randomness.

Warning: This Tesla Update Can Let Hackers Pull Off A Car Heist

A feature that Tesla, Inc. (NASDAQ: TSLA) announced in 2021 to make life easier for its car owners has provided a loophole for hackers to barge in.

$1000 Invested In This Stock 10 Years Ago Would Be Worth $11,000 Today

Electronic Arts (NASDAQ:EA) has outperformed the market over the past 10 years by 15.59% on an annualized basis producing an average annual return of 26.9%. Currently, Electronic Arts has a market capitalization of $37.35 billion.

Get all your
news in one place.

100’s of premium titles.
One news app.

$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today

CME Group (NASDAQ:CME) has outperformed the market over the past 10 years by 2.55% on an annualized basis producing an average annual return of 13.86%. Currently, CME Group has a market capitalization of $71.85 billion.

Tesla Files Proxy Statement Confirming Shareholder Vote for 3-for-1 Stock Split On Aug. 4

Tesla Inc (NASDAQ: TSLA) has finally confirmed after weeks of speculation that it has moved forward with plans for a stock split.

Analyzing Charter Communications's Short Interest

Charter Communications's (NASDAQ:CHTR) short percent of float has risen 22.52% since its last report. The company recently reported that it has 8.05 million shares sold short, which is 6.91% of all regular shares that are available for trading.

Here's How Much You Would Have Made Owning Dollar Tree Stock In The Last 20 Years

Dollar Tree (NASDAQ:DLTR) has outperformed the market over the past 20 years by 6.61% on an annualized basis producing an average annual return of 13.42%. Currently, Dollar Tree has a market capitalization of $35.20 billion.

Expert Ratings for ThredUp

Analysts have provided the following ratings for ThredUp (NASDAQ:TDUP) within the last quarter:

Analyst Ratings for Texas Instruments

Texas Instruments (NASDAQ:TXN) has observed the following analyst ratings within the last quarter:

Coinbase CEO Brian Armstrong Sees Bitcoin To Become A Global Reserve Currency, But These 3 Investors Disagree

Coinbase Global Inc. (NASDAQ: COIN) CEO Brian Armstrong stated his confidence that Bitcoin (CRYPTO: BTC) may become the new global reserve currency for the world.

1 … 391 392 393 394

People

Brian Armstrong

Sheryl Sandberg

Nassim Nicholas Taleb

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Electronic Arts

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play